Valuation: Acotec Scientific Holdings Limited

Market Cap 1.56B 1.82B 232M 207M 191M 174M 329M 22.06B 334M 2.3B 902M 11.51B 872M 854M 36.69B P/E 2026 *
11.5x
P/E 2027 * 9.19x
Enterprise Value 1.56B 1.82B 232M 207M 191M 174M 329M 22.06B 334M 2.3B 902M 11.51B 872M 854M 36.69B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.71x
Free-Float
16.41%
Yield 2026 *
-
Yield 2027 * -
1 day-0.43%
1 week-2.84%
Current month-7.77%
1 month-3.96%
3 months-29.88%
6 months-50.04%
Current year-56.89%
1 week 5.74
Extreme 5.735
6.05
1 month 5.5
Extreme 5.5
6.32
Current year 5.5
Extreme 5.5
15.32
1 year 5.5
Extreme 5.5
15.32
3 years 5.26
Extreme 5.26
15.47
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 28/01/2021
Chief Tech/Sci/R&D Officer 48 28/01/2021
Chief Tech/Sci/R&D Officer 85 28/01/2021
Director TitleAgeSince
Chairman 54 28/01/2021
Director/Board Member 56 02/12/2020
Director/Board Member 79 28/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
13/07/26 Other

Chief Executive Officer

-628,316 0.2005%
08/06/23 Other

Chief Executive Officer

7,208,000 2.3000%
24/09/21 Other

Chief Executive Officer

342,000 0.1091%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-2.84%-54.50%-54.53% 233M
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 117B
+0.49%+6.25%-20.20%+11.58% 112B
+3.83%+5.50%-44.18%-6.77% 76.56B
-0.14%+5.27%+6.74%+82.45% 65.15B
+2.79%+2.37%+15.93%+68.64% 52.79B
-1.04%+4.35%+3.50%-26.18% 52.78B
+2.41%+8.18%-12.08%+30.45% 43.11B
-1.90%+2.29%+29.72%+8.98% 33.1B
Average +0.63%+4.48%-9.32%+16.05% 73.42B
Weighted average by Cap. +0.60%+5.40%-9.54%+22.12%

Financials

2026 *2027 *
Net sales 728M 854M 109M 96.71M 89.64M 81.56M 154M 10.33B 156M 1.08B 422M 5.39B 408M 400M 17.18B 910M 1.07B 136M 121M 112M 102M 192M 12.91B 195M 1.35B 528M 6.74B 510M 500M 21.47B
Net income 128M 150M 19.13M 17M 15.76M 14.34M 27.06M 1.82B 27.49M 189M 74.28M 947M 71.79M 70.26M 3.02B 164M 192M 24.51M 21.79M 20.19M 18.37M 34.67M 2.33B 35.23M 243M 95.17M 1.21B 91.99M 90.03M 3.87B
Net Debt - -
Projected Income Statement - Annual - Acotec Scientific Holdings Limited
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
955
Date Price Change Volume
16/10/26 HK$5.820 -0.43% 614,000
15/10/26 HK$5.845 +1.12% 478,000
14/10/26 HK$5.780 -1.87% 580,000
13/10/26 HK$5.890 +0.17% 565,000
12/10/26 HK$5.880 -1.84% 471,000
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Acotec Scientific Holdings Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.962CNY
Average target price
15.00CNY
Spread / Average Target
+202.22%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Acotec Scientific Holdings Limited
  1. Stock Market
  2. Stocks
  3. 6669 Stock